Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.19.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Operating Expenses    
Research and development $ 2,474,559 $ 2,423,202
General and administrative 1,217,876 1,842,093
Sales and marketing 284,280 364,144
Total Operating Expenses 3,976,715 4,629,439
Operating Loss (3,976,715) (4,629,439)
Other Expense    
Interest expense 30,101 22,982
Other expenses 196,957
Total Other Expenses (227,058) (22,982)
Provision for Income Taxes
Net Loss (4,203,773) (4,652,421)
Other Comprehensive Income/(Loss)    
Foreign currency translation adjustments (24,054) 14,947
Net Comprehensive Loss $ (4,227,827) $ (4,637,474)
Net Loss per Share - Basic and Diluted $ (0.12) $ (0.17)
Weighted Average Shares Outstanding - Basic and Diluted 36,212,897 27,265,249